American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Eton Pharmaceuticals, Inc. (ETON)

$50.00 -0.04% NASDAQ: ETON · 15-min delayed

DEER PARK, Illinois
Public · NASDAQ: ETON
44 employees

Visit website Follow

$1.2BMarket cap

$80.0MRevenue · FY2025

-$4.6MNet income

44Employees

ETONNASDAQ

2018IPO

About Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NASDAQ: ETON
Employees: 44
IPO date: Nov 14, 2018
Headquarters: 21925 W. FIELD PARKWAY
DEER PARK, Illinois 60010-7278
Phone: (847) 787-7361
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: ETON Nasdaq
SEC CIK: 1710340
LEI: 549300I1AHR8KMMFIS52
EIN: 371858472
SIC: 2834 PHARMACEUTICAL PREPARATIONS

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Eton Pharmaceuticals, Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/eton-pharmaceuticals-inc/"><img src="https://americancompanies.com/badge/eton-pharmaceuticals-inc.svg" alt="Eton Pharmaceuticals, Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow Eton Pharmaceuticals, Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $80.0M
Net income: -$4.6M
Total assets: $92.1M
Market cap: $1.2B

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: ETON

$50.00 -0.04%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$14.35 $64.43

52-week range

Market cap: $1.2B
Shares outstanding: 23.3M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Nov 14, 2018

Eton Pharmaceuticals, Inc. (ETON) Stock Price

Reported a net loss of $4.6M in FY2025.
Trading 22% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Eton Pharmaceuticals, Inc..

Write a review

Newsroom

News about Eton Pharmaceuticals, Inc.

ETON Stock Surges 108% in Six Months: Here's What You Need to Know Zacks Investment Research · 2026-10-07 · positive Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference GlobeNewswire Inc. · 2026-08-27 · positive Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001 GlobeNewswire Inc. · 2026-08-05 · positive Eton Pharmaceuticals to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026 GlobeNewswire Inc. · 2026-08-03 · positive Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution Benzinga · 2026-03-02 · positive Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution GlobeNewswire Inc. · 2026-02-25 · positive

News & sentiment via Polygon.io

FAQ

Eton Pharmaceuticals, Inc.: frequently asked questions

Is Eton Pharmaceuticals, Inc. an American company?

Eton Pharmaceuticals, Inc. is a US-based company headquartered in Deer Park, Illinois, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Eton Pharmaceuticals, Inc. headquartered?

Eton Pharmaceuticals, Inc. is headquartered in Deer Park, Illinois, United States.

Is Eton Pharmaceuticals, Inc. publicly traded?

Yes — Eton Pharmaceuticals, Inc. is a publicly traded company. Its stock trades under the ticker symbol ETON on the NASDAQ.

What does Eton Pharmaceuticals, Inc. do?

Eton Pharmaceuticals, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore